Maravai Lifesciences Ownership

MRVI Stock  USD 3.22  0.17  5.57%   
Maravai Lifesciences maintains a total of 141.84 Million outstanding shares. The majority of Maravai Lifesciences outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Maravai Lifesciences Holdings to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Maravai Lifesciences. Please pay attention to any change in the institutional holdings of Maravai Lifesciences as this could imply that something significant has changed or is about to change at the company. Also note that almost nine hundred ninety-two thousand nine hundred eight invesors are currently shorting Maravai Lifesciences expressing very little confidence in its future performance.
Some institutional investors establish a significant position in stocks such as Maravai Lifesciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Maravai Lifesciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Maravai Stock Ownership Analysis

About 100.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.33. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Maravai Lifesciences recorded a loss per share of 1.67. The entity had not issued any dividends in recent years. Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California. Maravai LifeSciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 470 people. To find out more about Maravai Lifesciences Holdings contact the company at 858 546 0004 or learn more at https://www.maravai.com.

Maravai Lifesciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Maravai Lifesciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Maravai Lifesciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Maravai Lifesciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Deford John A a day ago
Acquisition by Deford John A of 31901 shares of Maravai Lifesciences subject to Rule 16b-3
 
Kevin Herde over a week ago
Disposition of 2326 shares by Kevin Herde of Maravai Lifesciences at 4.1 subject to Rule 16b-3
 
Christine Dolan over a week ago
Disposition of 1621 shares by Christine Dolan of Maravai Lifesciences at 4.1 subject to Rule 16b-3
 
Christine Dolan over two weeks ago
Acquisition by Christine Dolan of 55775 shares of Maravai Lifesciences subject to Rule 16b-3
 
Kurt Oreshack over a month ago
Disposition of 25000 shares by Kurt Oreshack of Maravai Lifesciences at 5.03 subject to Rule 16b-3
 
Eckert R Andrew over two months ago
Acquisition by Eckert R Andrew of 134409 shares of Maravai Lifesciences subject to Rule 16b-3
 
Lucier Gregory T over two months ago
Acquisition by Lucier Gregory T of 20645 shares of Maravai Lifesciences subject to Rule 16b-3
 
Rebecca Buzzeo over three months ago
Acquisition by Rebecca Buzzeo of 288198 shares of Maravai Lifesciences subject to Rule 16b-3
 
Gtcr Investment Xi Llc over three months ago
Disposition of 8409946 shares by Gtcr Investment Xi Llc of Maravai Lifesciences subject to Rule 16b-3
 
Andrew Burch over three months ago
Acquisition by Andrew Burch of 1841 shares of Maravai Lifesciences at 5.7 subject to Rule 16b-3
 
Kevin Herde over three months ago
Acquisition by Kevin Herde of 1861 shares of Maravai Lifesciences at 5.83 subject to Rule 16b-3
 
Gray Susannah over three months ago
Acquisition by Gray Susannah of 24000 shares of Maravai Lifesciences subject to Rule 16b-3

Maravai Lifesciences Outstanding Bonds

Maravai Lifesciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Maravai Lifesciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Maravai bonds can be classified according to their maturity, which is the date when Maravai Lifesciences Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

When determining whether Maravai Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Maravai Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Maravai Lifesciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Maravai Lifesciences Holdings Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.